ATE301644T1 - Tricyclische laktam- und sultamderivate und deren verwendung als inhibitoren der histondeacetylase - Google Patents

Tricyclische laktam- und sultamderivate und deren verwendung als inhibitoren der histondeacetylase

Info

Publication number
ATE301644T1
ATE301644T1 AT02714107T AT02714107T ATE301644T1 AT E301644 T1 ATE301644 T1 AT E301644T1 AT 02714107 T AT02714107 T AT 02714107T AT 02714107 T AT02714107 T AT 02714107T AT E301644 T1 ATE301644 T1 AT E301644T1
Authority
AT
Austria
Prior art keywords
histone deacetylase
deacetylase inhibitors
tricyclic lactam
sultam derivatives
sultam
Prior art date
Application number
AT02714107T
Other languages
English (en)
Inventor
Guy Georges
Adelbert Grossmann
Olaf Mundigl
Der Saal Wolfgang Von
Tim Sattelkau
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE301644T1 publication Critical patent/ATE301644T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • C07D209/92—Naphthostyrils

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT02714107T 2001-01-27 2002-01-24 Tricyclische laktam- und sultamderivate und deren verwendung als inhibitoren der histondeacetylase ATE301644T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01101873 2001-01-27
PCT/EP2002/000705 WO2002062773A1 (en) 2001-01-27 2002-01-24 Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors

Publications (1)

Publication Number Publication Date
ATE301644T1 true ATE301644T1 (de) 2005-08-15

Family

ID=8176314

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02714107T ATE301644T1 (de) 2001-01-27 2002-01-24 Tricyclische laktam- und sultamderivate und deren verwendung als inhibitoren der histondeacetylase

Country Status (15)

Country Link
US (1) US7091229B2 (de)
EP (1) EP1358168B1 (de)
JP (1) JP3961955B2 (de)
KR (1) KR100628013B1 (de)
CN (1) CN1216047C (de)
AR (1) AR035417A1 (de)
AT (1) ATE301644T1 (de)
AU (1) AU2002246053B2 (de)
BR (1) BR0206738A (de)
CA (1) CA2432196C (de)
DE (1) DE60205454T2 (de)
ES (1) ES2248531T3 (de)
MX (1) MXPA03006422A (de)
WO (1) WO2002062773A1 (de)
ZA (1) ZA200305382B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7250514B1 (en) 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
GB0226855D0 (en) 2002-11-18 2002-12-24 Queen Mary & Westfield College Histone deacetylase inhibitors
US7375228B2 (en) 2003-03-17 2008-05-20 Takeda San Diego, Inc. Histone deacetylase inhibitors
WO2005058298A2 (en) * 2003-12-10 2005-06-30 Wisconsin Alumni Research Foundation Fk228 analogs and their use as hdac-inhibitors
WO2005065681A1 (en) * 2003-12-19 2005-07-21 Takeda San Diego, Inc. N- hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide derivatives and related compounds as histone deacetylase (hdac) inhibitors for the treatment of cancer
US20050137234A1 (en) * 2003-12-19 2005-06-23 Syrrx, Inc. Histone deacetylase inhibitors
CN101001851B (zh) * 2004-08-09 2011-04-20 安斯泰来制药有限公司 具有作为组蛋白脱乙酰酶(hdac)抑制剂的活性的羟基酰胺化合物
US7642275B2 (en) * 2004-12-16 2010-01-05 Takeda San Diego, Inc. Histone deacetylase inhibitors
US20100087328A1 (en) * 2005-03-01 2010-04-08 The Regents Of The University Of Michigan Brm expression and related diagnostics
WO2006094068A2 (en) * 2005-03-01 2006-09-08 The Regents Of The University Of Michigan Hdac inhibitors that promote brm expression and brm related diagnostics
JP2008540574A (ja) * 2005-05-11 2008-11-20 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
CA2615105A1 (en) * 2005-07-14 2007-01-25 Takeda San Diego, Inc. Histone deacetylase inhibitors
EP2275096A3 (de) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenese durch modulation des Muscarinrezeptors
EP2258357A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP2314289A1 (de) 2005-10-31 2011-04-27 Braincells, Inc. Gaba-rezeptor-vermittelte modulation von neurogenese
EP1976835A2 (de) * 2006-01-13 2008-10-08 Takeda San Diego, Inc. Histondeacetylase-inhibitoren
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2021000A2 (de) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenese mittels angiotensin-modulation
ES2288803B1 (es) * 2006-07-07 2008-12-16 Universidad De Granada Derivados de benzo(d)isotiazoles como inhibidores de las histonas desacetilasas.
WO2008030651A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
GB0620823D0 (en) 2006-10-19 2006-11-29 Univ London Histone deacetylase inhibitors
CA2691987C (en) * 2007-06-12 2016-08-16 Achaogen, Inc. Antibacterial agents
US8034768B2 (en) * 2007-06-22 2011-10-11 Board Of Regents, The University Of Texas System Composition and method for the treatment of diseases affected by histone deacetylase inhibitors
JP2010536876A (ja) * 2007-08-21 2010-12-02 アークル インコーポレイテッド Ｈｄａｃインヒビター
CA2706750A1 (en) * 2007-11-27 2009-06-04 Ottawa Health Research Institute Amplification of cancer-specific oncolytic viral infection by histone deacetylase inhibitors
US8293513B2 (en) * 2007-12-14 2012-10-23 Georgetown University Histone deacetylase inhibitors
WO2010011700A2 (en) 2008-07-23 2010-01-28 The Brigham And Women's Hospital, Inc. Treatment of cancers characterized by chromosomal rearrangement of the nut gene
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AU2010232647A1 (en) * 2009-03-31 2011-10-20 Arqule, Inc. Peri-fused pyrazolo-pyrimidine compounds
EP3062783B1 (de) 2013-10-18 2020-08-12 The General Hospital Corporation Bildgebung von histondeacetylasen mit einem radiotracer mittels positronenemissionstomografie

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
AUPO721997A0 (en) * 1997-06-06 1997-07-03 Queensland Institute Of Medical Research, The Anticancer compounds
WO1999033804A1 (en) * 1997-12-25 1999-07-08 Meiji Seika Kaisha, Ltd. Tetrahydrobenzindole derivatives
US6271222B1 (en) * 1998-05-28 2001-08-07 Merck & Co., Inc. Penem antibacterial compounds, compositions and methods of treatment
US6221859B1 (en) * 1999-08-27 2001-04-24 Merck & Co., Inc. Carbapenem antibacterial compositions and methods of the treatment

Also Published As

Publication number Publication date
US20040077698A1 (en) 2004-04-22
EP1358168A1 (de) 2003-11-05
CN1487925A (zh) 2004-04-07
BR0206738A (pt) 2004-02-03
DE60205454D1 (de) 2005-09-15
EP1358168B1 (de) 2005-08-10
ES2248531T3 (es) 2006-03-16
MXPA03006422A (es) 2003-10-15
AR035417A1 (es) 2004-05-26
CA2432196C (en) 2007-11-27
ZA200305382B (en) 2004-10-11
CN1216047C (zh) 2005-08-24
JP2004517956A (ja) 2004-06-17
DE60205454T2 (de) 2006-03-30
WO2002062773A1 (en) 2002-08-15
JP3961955B2 (ja) 2007-08-22
CA2432196A1 (en) 2002-08-15
KR100628013B1 (ko) 2006-09-26
KR20030072607A (ko) 2003-09-15
US7091229B2 (en) 2006-08-15
AU2002246053B2 (en) 2005-02-17

Similar Documents

Publication Publication Date Title
DE60205454D1 (de) Tricyclische laktam- und sultamderivate und deren verwendung als inhibitoren der histondeacetylase
DE60133897D1 (de) Substituierte chinazolin-derivate und deren verwendung als aurora-2-kinase inhibitoren
DE60020100D1 (de) Dimerverbindungen und als inhibitoren der neuramidinase
DE60308998D1 (de) N-aryl-2-oxazolidinon-5-carbonsäureamide und deren derivate und deren verwendung als antibakterielle mittel
DE59913617D1 (de) Indolderivate und deren Verwendung als Inhibitoren der Phosphodiesterase 4.
ATE463482T1 (de) Chinolinderivate und deren verwendung als mycobakterielle inhibitoren
DE60221233D1 (de) Neue spirotricyclische derivate und deren verwendung als phosphodiesterase-7-inhibitoren
DK1465615T3 (da) Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf
DE60131015D1 (de) Bakterielle gyrase-hemmer und deren verwendung
ATE446950T1 (de) Bipiperidin-derivate und ihre verwendung als inhibitoren der chemokinrezeptoren
ATE419849T1 (de) Diaminotriazole derivate und deren verwendung als protein kinase inhibitoren
DE602004021037D1 (de) Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren
DE60030574D1 (de) Fünfgliedrige derivate von heterozyklen und ihre verwendung als monoaminoxidase-inhibitoren
ATE424395T1 (de) Aminoderivate als histone-deacetylase-inhibitoren
DE60321548D1 (de) Carbonylamino- derivativate als neue inhibitoren von histone deacetylase
DE60103974D1 (de) Gyrase-inhibitoren und ihre verwendung
DE60319951D1 (de) Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate
DE50105955D1 (de) Indol-3-yl-derivate und deren verwendung als integrin-inhibitoren
DE60303376D1 (de) Benzoxazinderivate als 5-ht6-modulatoren und deren verwendungen
DK1554250T3 (da) Hidtil ukendt lactamer og anvendelser deraf
ATE382040T1 (de) Acylaminothiazolderivate und ihre vewrendung als beta-amyloid inhibitoren
DE60322551D1 (de) 2,4-substituierte indole und deren verwendung als 5-ht6 modulatoren
DE50206476D1 (de) Cyanoanthranylamid-derivate und deren verwendung als arzneimittel
DE60037183D1 (de) Neue amidinbenzylamin-derivate und ihre verwendung als thrombin-inhibitoren
DE60311598D1 (de) Naphthyridin-derivate und ihre verwendung als fungizide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1358168

Country of ref document: EP

REN Ceased due to non-payment of the annual fee